Esperion Therapeutics Inc (fra:0ET) Share Price

Company Profile

Business description
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
Contact
3891 Ranchero Drive
Suite 150
Ann ArborMI48108
USA
T: +1 734 887-3903
E: [email protected]
https://www.esperion.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
304

Recommended

Acquisition unlikely to improve prospects in the US and detracts from other opportunities.

Roy Van Keulen | 15 September 2025

Finding value in an expensive market.

Simonelle Mody | 15 September 2025

Does recent share price weakness spell opportunity in these three high-quality companies? Our analysts think so.

Joseph Taylor | 11 September 2025

Index	Last price	Change	% Change
All Ordinaries	9,120.90	34.10	0.38%
CAC 40	7,896.93	71.69	0.92%
DAX 40	23,748.86	50.71	0.21%
Dow JONES (US)	45,832.66	1.56	-0.00%
FTSE 100	9,277.03	6.26	-0.07%
HKSE	26,446.56	58.40	0.22%
NASDAQ	22,346.54	205.43	0.93%
Nikkei 225	44,768.12	395.62	0.89%
NZX 50 Index	13,208.31	19.59	-0.15%
S&P 500	6,617.01	32.72	0.50%
S&P/ASX 200	8,853.00	31.60	0.36%
SSE Composite Index	3,860.50	10.09	-0.26%